Cost-effectiveness analysis of cardiac resynchronization therapy in patients with NYHA I and NYHA II heart failure in Spain.

Autores de IIS La Fe

• Luis Almenar Bonet

  Autor

• Anastasio Quesada Carmona

  Autor

Participantes ajenos a IIS La Fe

• Díaz B
• Crespo C
• Martí B
• Mealing S
• Linde C
• Daubert C

Abstract

The aim of the study was to combine clinical results from the European Cohort of the REVERSE study and costs associated with the addition of cardiac resynchronization therapy (CRT) to optimal medical therapy (OMT) in patients with mild symptomatic (NYHA I-II) or asymptomatic left ventricular dysfunction and markers of cardiac dyssynchrony in Spain.